Literature DB >> 7226044

Prognostic significance of histologic host response in cancer of the large bowel.

L Nacopoulou, P Azaris, N Papacharalampous, P Davaris.   

Abstract

Histologic material from 156 patients treated with surgery for cancer of the large bowel was studied with regard to tumor host interaction and with particular emphasis on the reactions of the regional lymph nodes. Prognostic evaluation of the tumor included the extent of the primary lesion according to Dukes' classification and the grade of differentiation of the carcinoma. Morphologic evidence of host resistance was judged by the presence and degree of lymphoplasmacytic infiltration of the tumor and the reactions of the regional lymph nodes, which were classified in four histologic patterns: lymphocyte predominance, germinal center predominance, lymphocyte depletion, and unstimulated. Of the factors evaluated, those that appeared to correlate best with five-year survival were the stage of the disease, the grade of differentiation of the carcinoma, the degree of lymphoplasmacytic infiltration of the tumor, the lymphocyte predominance pattern, and, to a lesser degree, the germinal center predominance pattern. None of the other morphologic features related to lymph nodes showed favorable prognostic significance. The relationship of morphology to host immune mechanisms is discussed.

Entities:  

Mesh:

Year:  1981        PMID: 7226044     DOI: 10.1002/1097-0142(19810301)47:5<930::aid-cncr2820470519>3.0.co;2-1

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  14 in total

1.  Lymph node evaluation for colon cancer in routine clinical practice: a population-based study.

Authors:  J C Del Paggio; S Nanji; X Wei; P H MacDonald; C M Booth
Journal:  Curr Oncol       Date:  2017-02-27       Impact factor: 3.677

2.  Impaired CD95 expression predisposes for recurrence in curatively resected colon carcinoma: clinical evidence for immunoselection and CD95L mediated control of minimal residual disease.

Authors:  J Sträter; U Hinz; C Hasel; U Bhanot; G Mechtersheimer; T Lehnert; P Möller
Journal:  Gut       Date:  2005-05       Impact factor: 23.059

3.  Lymph node hypoplasia is associated with adverse outcomes in node-negative colon cancer using advanced lymph node dissection methods.

Authors:  Patrick Mayr; Georg Aumann; Tina Schaller; Gerhard Schenkirsch; Matthias Anthuber; Bruno Märkl
Journal:  Langenbecks Arch Surg       Date:  2016-02-16       Impact factor: 3.445

4.  Association of macrophages detected with monoclonal antibody 25 F 9 with progression and pathobiological classification of gastric carcinoma.

Authors:  G Heidl; P Davaris; G Zwadlo; M S Jagoda; S Düchting; E Bierhoff; T Grüter; V Krieg; C Sorg
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

5.  A case of lymphoepithelioma-like carcinoma of the colon with ulcerative colitis.

Authors:  Yasuyuki Kojima; Masatoshi Mogaki; Ryo Takagawa; Ikuko Ota; Mitsutaka Sugita; Shiho Natori; Yohei Hamaguchi; Haruki Kurosawa; Tadao Fukushima; Hidenobu Masui; Shingo Fukazawa; Shoji Yamanaka; Yukio Tsuura; Kaoru Nagahori
Journal:  J Gastroenterol       Date:  2007-03-12       Impact factor: 7.527

6.  Carcinoma with lymphoid stroma of the gallbladder--a case report.

Authors:  Y Muto; Y Sho; M Uchimura
Journal:  Jpn J Surg       Date:  1984-09

7.  Immunohistochemical expression of C-myc oncogene, heat shock protein 70 and HLA-DR molecules in malignant cutaneous melanoma.

Authors:  A C Lazaris; G E Theodoropoulos; K Aroni; A Saetta; P S Davaris
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

8.  Lymphoepithelioma-like carcinoma of the colon.

Authors:  Yasuharu Mori; Kazunari Akagi; Masaaki Yano; Hiroshi Sashiyama; Osamu Tsutsumi; Yukihiro Hamahata; Yasunobu Tsujinaka; Akihiko Tsuchida; Jun Matsubayashi
Journal:  Case Rep Gastroenterol       Date:  2013-03-13

9.  Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer.

Authors:  S Ganesh; C F Sier; M M Heerding; J H van Krieken; G Griffioen; K Welvaart; C J van de Velde; J H Verheijen; C B Lamers; H W Verspaget
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

10.  HLA antigens in colorectal tumours--low expression of HLA class I antigens in mucinous colorectal carcinomas.

Authors:  H F van den Ingh; D J Ruiter; G Griffioen; G N van Muijen; S Ferrone
Journal:  Br J Cancer       Date:  1987-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.